PFE

Pfizer Inc.
Data: 2026-07-31

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Quick Stats
Jul 31, 2026

55.8

AI Score

HOLD

0.96

Volume Ratio

Aug 04, 2026

Next Earnings

13

+ve Days (30d)

17

-ve Days (30d)

PFE Stock Summary

Last updated Jul 31, 2026

PFE is currently trading at $25.01, positioned below its 200-day moving average of $25.83, suggesting bearish momentum. The stock has a 52-week range of $23.11 to $28.745.

Technical Analysis: The 50-day moving average stands at $25.08, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 52.279, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.081, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates PFE at 55.8/100 with a HOLD recommendation.

PFE (Pfizer Inc.) Indicators

Last updated Jul 31, 2026

Indicator Value
RSI(14) 52.279
CMF (20) -0.081
ROC (10) -0.16
ADX (14) 17.526
Indicator Value
MACD (12,26,9) 0.029
AROONOSC (14) 21.429
WILLAMS %R (14) -42.244
MFI (14) 61.315
PFE Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

PFE Price vs Max Options Open Interest
PFE Max Change In Options Open Interest

PFE Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PFE Daily Out of Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PFE Daily In the Money Options - Sort by Max open Interest (near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

PFE Most Active Options by Volume(near term)

3rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Pfizer Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.

PFE Moving Averages Analysis

PFE (Pfizer Inc.) Simple Moving Averages

Moving Averages are last updated Jul 31, 2026

Days MA
10 24.9
20 24.65
30 24.56
50 25.08
100 25.98
200 25.83

PFE Fundamental Analysis

P/E (Forward) 8.5837
P/E (Trailing) 19.0153
Market Cap ($) 143.3 billion
Earnings/Share ($) 1.31
Net Profit Margin (%) 0.1183
Dividend/Share ($) 1.72
EPS Estimate Current Year ($) 2.9448
EPS Estimate Next Year ($) 2.8318
WallStreet Target Price ($) 28.75
Most Recent Quarter